NASDAQ: JSPRJasper Therapeutics Inc Stock Ownership - Who owns Jasper Therapeutics?
Insider buying vs selling
Have Jasper Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Svetlana Lucas | Director | 2025-09-22 | 20,000 | $2.43 | $48.60kBuy |
| Ron Martell | President and CEO | 2025-09-22 | 41,000 | $2.43 | $99.63kBuy |
| Judith Anne Shizuru | Director | 2025-09-22 | 41,000 | $2.43 | $99.63kBuy |
| Thomas G. Wiggans | Director | 2025-09-22 | 41,000 | $2.43 | $99.63kBuy |
JSPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when JSPR insiders and whales buy or sell their stock.
JSPR Shareholders
What type of owners hold Jasper Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Roche Holding Ltd | 27.57% | 9,174,212 | $6.29M | Insider |
| Qiming Us Healthcare Fund II LP | 25.60% | 8,519,648 | $5.84M | Insider |
| Barney A. Richmond | 19.43% | 6,464,048 | $4.43M | Insider |
| Kurt Von Emster | 16.98% | 5,649,733 | $3.88M | Insider |
| Abingworth LLP | 16.92% | 5,628,558 | $3.86M | Insider |
| Amplitude Healthcare Holdings LLC | 6.91% | 2,300,000 | $1.58M | Insider |
| Kenneth F. Clifford | 6.91% | 2,300,000 | $1.58M | Insider |
| Balaji Venkataraman | 6.91% | 2,300,000 | $1.58M | Insider |
| Howard I. Hoffen | 6.91% | 2,300,000 | $1.58M | Insider |
| Velan Capital Investment Management LP | 4.31% | 1,433,828 | $983.61k | Insider |
JSPR vs Biotech Stocks
Jasper Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.